18 days ago
AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
What's happening
SignalsMonitor is following this as a politics story. South China Morning Post Asia is the outlet attached so far. The first report grouped here was at 29 Sept 2026, 09:00 UTC. The headline in use is “AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
Reported by 1 outlet
- South China Morning Post
- South China Morning PostAstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows